Frequency Of Diabetic Retinopathy In Known Diabetic Patients Visiting The Eye Clinic Severity Distribution, Associated Risk Factors.
Keywords:
Diabetic retinopathy, diabetes, prevalence, risk factorsAbstract
most common causes of blindness. The impact of DR is increasing and is most prevalent in the low- and middle-income countries of the world, where screening is still virtually nonexistent. Assessing the prevalence and severity of DR in already diagnosed diabetics is of great importance in establishing a basis for the prompt initiation of targeted interventions aimed at mitigating vision loss.
Objectives: To establish how common and how serious diabetic retinopathy is among diabetic patients going to the eye clinic, as well as to determine principal associated risk factors: duration of the diabetes condition, high blood pressure, and poor control of glycemia.
Methodology: this study conducted at department of Ophthalmology, Gajju Khan Medical College Swabi from july to dec 2024.One hundred diabetic participants aged 18 years and older were recruited in a cross-sectional study at an ophthalmology clinic. HbA1c levels were checked, and clinic-demographic data, comorbid conditions, and diabetes duration were collected. All participants underwent slit-lamp bio microscopy after pupillary dilation with an examination of the microscope after diabetic retinopathy (DR) had been graded with the International Clinical DR Classification. All data were input into SPSS 24.0, and simple computations (frequencies, percentages, means, and standard deviation) were calculated. The chi-square test was employed to assess the relationships among variables and DR. Independent factors were identified using logistic regression analysis. A two-tailed p-value of 0.05 was employed as the threshold for statistical significance.
Results: 100 diabetic patients with an average age of 55.4 ± 10.2 years, 59% of the sample were male. 42% of the diabetic patients had diabetic retinopathy. In terms of severity, 14% had mild NPDR, 16% had moderate NPDR, 5% had severe NPDR and 7% had PDR. Diabetic macular edema was evident within 11% of the patients. HbA1c (≥8%) demonstrated a significant relationship with DR due to poor glycemic control (p=0.003). Diabetic patients who had had the disease for more than 10 years had DR at a significantly (p=0.001) higher rate. In terms of associations, hypertension was significant (p=0.04) while the variable of gender was not (p=0.28). In the logistic regression HbA1c≥8% (OR 3.8) along with duration of diabetes (OR 4.1) and hypertension (OR 1.9) were significant.
Conclusion: All patients diagnosed with diabetes have diabetic retinopathy, with almost half of them having some sort of involvement of the tracheae. Diabetic retinopathy (DR) has an even greater risk factor with increased years of diabetes, poor glycemic control, and high blood pressure. These results should highlight the importance of regular eye examinations, better control of diabetes without complications, and early referrals to help prevent vision loss. Improving vision loss assessments in those who have diabetes should be a major focus to alleviate the impact of unnecessary sight loss in these patients
Downloads
References
Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular Complications of Type 2 Diabetes Mellitus. Current vascular pharmacology. 2020;18(2):117-24.
2. Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, et al. Diabetic Retinopathy Preferred Practice Pattern®. Ophthalmology. 2020;127(1):P66-p145.
3. Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. Journal of diabetes investigation. 2021;12(8):1322-5.
4. Lin T, Gubitosi-Klug RA, Channa R, Wolf RM. Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management. Current diabetes reports. 2021;21(12):56.
5. Rajalakshmi R, UmaSankari G, Sivaprasad S, Venkatesan U, Kumpatla S, Shanthirani CS, et al. Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians. Journal of diabetes and its complications. 2022;36(3):108131.
6. Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. Journal of global health. 2018;8(1):010803.
7. Sun XJ, Zhang GH, Guo CM, Zhou ZY, Niu YL, Wang L, et al. Associations between psycho-behavioral risk factors and diabetic retinopathy: NHANES (2005-2018). Frontiers in public health. 2022;10:966714.
8. Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021;128(11):1580-91.
9. Vilsbøll T, Bain SC, Leiter LA, Lingvay I, Matthews D, Simó R, et al. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes, obesity & metabolism. 2018;20(4):889-97.
10. Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and risk factors of diabetic retinopathy in diabetic patients: A community based cross-sectional study. Medicine. 2020;99(9):e19236.
11. Castillo-Otí JM, Cañal-Villanueva J, García-Unzueta MT, Galván-Manso AI, Callejas-Herrero MR, Muñoz-Cacho P. [Prevalence and risk factors associated with diabetic retinopathy in Santander. Northern Spain]. Atencion primaria. 2020;52(1):29-37.
12. Gelcho GN, Gari FS. Time to Diabetic Retinopathy and Its Risk Factors among Diabetes Mellitus Patients in Jimma University Medical Center, Jimma, Southwest Ethiopia. Ethiopian journal of health sciences. 2022;32(5):937-46.
13. Hou Y, Cai Y, Jia Z, Shi S. Risk factors and prevalence of diabetic retinopathy: A protocol for meta-analysis. Medicine. 2020;99(42):e22695.
14. Jiang W, Wang J, Shen X, Lu W, Wang Y, Li W, et al. Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts. Diabetes care. 2020;43(4):925-33.
15. Laiginhas R, Madeira C, Lopes M, Neves JS, Barbosa M, Rosas V, et al. Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes. Endocrine. 2019;66(2):201-9.
16. Ma Y, Wang H, Jiang J, Han C, Lu C, Zeng S, et al. Prevalence of and risk factors for diabetic retinopathy in residents with different types of abnormal glucose metabolism with or without hypertension: A suburban community-based cross-sectional study. Frontiers in endocrinology. 2022;13:966619.
17. Porta M, Striglia E. Intravitreal anti-VEGF agents and cardiovascular risk. Internal and emergency medicine. 2020;15(2):199-210.
18. Syriga M, Ioannou Z, Pitsas C, Dagalaki I, Karampelas M. Diabetic retinopathy in Greece: prevalence and risk factors studied in the medical retina clinic of a Greek tertiary hospital. International ophthalmology. 2022;42(6):1679-87.
19. Tan H, Wang X, Ye K, Lin J, Song E, Gong L. Prevalence and risk factors of diabetic retinopathy among Chinese adults with type 2 diabetes in a suburb of Shanghai, China. PloS one. 2022;17(10):e0275617.
20. Wang H, Guo Z, Xu Y. Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes. Journal of translational medicine. 2022;20(1):219.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.